A Misdiagnosis Leads to an Unexpected Discovery for a Father of Three

When Andy Provencher took a tumble from his mountain bike, his immediate concern was how his wife would react to his fall.

This incident occurred in June 2020 amidst the height of the COVID-19 pandemic. The emergency room was a place his wife was particularly apprehensive about during such times. Andy, who is a father to three children, ended up with multiple fractures and a pierced lung. However, doctors discovered something even more alarming.

Provencher recounted, "The doctor in the ER informed me that scans revealed my lungs to be dotted with masses indicative of an aggressive lung cancer."

A Year of Uncertainty and Search for Answers

This shocking news initiated a year-long quest for clarity. Diagnoses fluctuated frequently, with several physicians believing Provencher to be battling terminal lung cancer, but confirming tests were elusive.

Provencher, who is 45, shared, "I visited every specialist available, including my primary care, a hematologist, pulmonologist, and rheumatologist, but no definitive diagnosis emerged."

The Suggestion that Changed Everything

His health deteriorated; simple activities like climbing stairs became exhausting, and he was advised to start chemotherapy soon.

Two weeks prior to the planned treatment, a physician’s assistant, after learning about IgG4-Related Disease (IgG4-RD) in a rheumatology course, suspected it could be Provencher's condition. This insight led Provencher to quickly seek counsel from Dr. John Stone, an authority on the rare disease.

Following diagnostic tests, Stone provided a definitive diagnosis, providing clarity after a chaotic year. Provencher noted, "It felt like the world stopped spinning when Dr. Stone explained things—it was like a weight lifted."

Understanding IgG4-RD

IgG4-RD is a rare systemic inflammatory condition that can cause tissue lesions and scarring in nearly any bodily organ, explained Dr. Ambreesh Chawla from the Cleveland Clinic. Commonly affected areas include the pancreas, liver, salivary glands, and lymph nodes, yet it can extend to the lungs and central nervous system too.

The disease progresses slowly, often causing organ damage before symptoms become noticeable. It lacks a straightforward diagnostic test and resembles various other illnesses, leading to frequent misdiagnosis.

Pioneering Clinical Trials

Dr. Stone involved Provencher in a landmark trial testing inebilizumab to manage IgG4-RD. This antibody treatment targets CD19 on B cells, aiming to reduce disease flares.

In the initial phase, patients received either the drug with steroids or just steroids. The goal was FDA approval for the first treatment for IgG4-RD. Provencher suspected being part of the control group initially but experienced notable improvements in the later trial phase.

Life After Diagnosis

Three years following his diagnosis, Provencher continues his treatment with inebilizumab, finding his quality of life significantly improved. While past damage persists, he remains optimistic about managing his condition.

He and his wife are now active in advocacy through the IgG4ward! Foundation, striving to spread awareness and aid others in avoiding similar misdiagnostic experiences. Provencher emphasizes the importance of perseverance: "Always ask questions and keep moving forward."